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Abstract: 30 
We have developed a system for producing a supramolecular scaffold that permeates the 31 
entire Escherichia coli cytoplasm. This cytoscaffold is constructed from a three-component 32 
system comprising a bacterial microcompartment shell protein and two complementary de 33 
novo coiled-coil peptides. We show that other proteins can be targeted to this intracellular 34 
filamentous arrangement. Specifically, the enzymes pyruvate decarboxylase and alcohol 35 
dehydrogenase have been directed to the filaments, leading to enhanced ethanol production 36 
in these engineered bacterial cells compared with those that do not produce the scaffold.  37 
This is consistent with improved metabolic efficiency through enzyme colocation.  Finally, 38 
the shell-protein scaffold can be directed to the inner membrane of the cell, demonstrating 39 
how synthetic cellular organization can be coupled with spatial optimization through in-cell 40 
protein design. The cytoscaffold has potential for the development of next-generation cell 41 
factories, where it could be used to organize enzyme pathways and metabolite transporters 42 
to enhance metabolic flux. 43 
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Introduction: 45 
In industrial biotechnology and synthetic biology there is a growing need to generate internal 46 
bacterial supramolecular scaffolds en route to delivering so-called cell factories1. To this end, 47 
researchers have investigated protein-based linkers2, lipids3 and nucleic acids4,5 as 48 
modulators to attain high-level biomolecular organization. However, none of these 49 
approaches have delivered a uniform matrix throughout a bacterial cytoplasm. The 50 
advantage of such scaffolding systems is that they can be used to direct and align 51 
biosynthetic pathway enzymes to orchestrate greater production of commodity and speciality 52 
chemicals, especially in pathways that proceed through unstable or toxic intermediates6,7. 53 
This is because the close proximity of enzymes on a scaffold allow for greater channeling of 54 
intermediates through improved flux, stabilization of intermediates and protection from other 55 
reactions8,9. 56 
A number of natural scaffolds are found in bacterial cells. For instance, bacterial 57 
microcompartments (BMCs) are organelles with an outer semi-permeable scaffold in the 58 
form of a protein shell, which encases a specific metabolic pathway10-12.  BMCs have a 59 
diameter of approximately 150 nm and possess high concentrations of internalized 60 
enzymes. This is most apparent in carboxysomes, which are anabolic BMCs where the high 61 
concentrations of carbonic anhydrase and RuBisCO ensure enhanced carbon fixation13,14. In 62 
catabolic BMCs, such as the metabolosome associated with propanediol utilization (the so-63 
called Pdu system), internalized enzymes necessitate that propionaldehyde is rapidly 64 
transformed into either an alcohol or a CoA thioester, thereby protecting the cell from the 65 
potentially toxic aldehyde intermediate15-17. In all cases, the enzymes are targeted to the 66 
interior of the BMCs by small encapsulation peptides, which interact with a component of the 67 
outer shell scaffold18-21. Modelling studies indicate that BMCs enhance flux through 68 
intermediate sequestration22. Recently, a detailed structure of a recombinant BMC shell has 69 
been reported, showing the precise orientation of the different shell proteins that tile together 70 
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to form the outer casing, providing molecular detail on how the shell proteins scaffold 71 
together to act as a semi-permeable membrane23. 72 
Apart from BMCs, the other major scaffold within prokaryotic cells is the cytoskeleton24, 73 
which is generally distributed around the inner membrane. This filamentous structure, which 74 
includes protein components such as FtsZ, MreB, ParM and MinD25,26, has roles in cell 75 
division, cell morphology and structural polarity.  However, the essential nature of these 76 
proteins precludes them from being developed as major cellular matrices. For these 77 
reasons, we sought to construct a simple and modular bacterial cytoskeleton, which we call 78 
a cytoscaffold, from components that we understand and can manipulate predictably. 79 
Previously, we showed that a single shell protein from the Citrobacter freundii propanediol 80 
utlisation (Pdu) BMC, with a minor modification to its C terminus to improve solubility 81 
(PduA*), forms filaments in E. coli27. PduA itself hexamerizes to form a tile that assembles to 82 
make the facets of the BMC casing28,29. However, when overproduced recombinantly in E. 83 
coli, PduA* forms hollow filaments approx. 20 nm in diameter that span the length of the 84 
cell30. Moreover, these structures often interfere with septation during cell division. 85 
Nonetheless, we reasoned that PduA*-based filamentous structures could present tractable 86 
scaffolds for tethering other proteins.  87 
Here, we describe a three-component system comprising PduA and two complementary de 88 
novo-designed coiled-coil peptides31, which form an interactive intracellular filamentous 89 
arrangement that gives the appearance of a matrix that permeates the entire E. 90 
coli cytoplasm (Supplementary Fig. 1). We show that other proteins can be specifically 91 
targeted to these cytoscaffolds.  Building on this, we demonstrate that tethering metabolic 92 
enzymes for ethanol production to the PduA scaffold increases their effective local and 93 
relative concentrations, and results in improved ethanol production. Finally, we show that the 94 
scaffold can be directed to the inner membrane of the cell, further illustrating its modularity, 95 
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flexibility, and utility, and demonstrating how synthetic cellular organization can be coupled 96 
with spatial optimization. 97 
Results: 98 
Construction of a filamentous scaffold. Initially, we tested if different proteins could be 99 
recruited to PduA* filaments in vivo in an analogous way to how encapsulation peptides are 100 
thought to work in natural BMCs (vide supra). Attempts to use the natural encapsulation 101 
peptides themselves were not very successful mainly due to aggregation within the cell32. 102 
Therefore, we turned to a better-characterized de novo designed heterodimeric coiled-coil 103 
system, CC-Di-AB (ref. 31), which has been used successfully to construct self-assembling 104 
peptide cages33. The heterodimer comprises two peptides (acidic (A) and basic (B)) that do 105 
not self-associate, but do interact specifically and tightly when mixed. The concept was to 106 
fuse either CC-Di-A or CC-Di-B to PduA*, and then test if a reporter protein with the cognate 107 
peptide could be targeted to the filaments. Plasmids encoding fusion proteins of the 108 
following type were made: CC-Di-A/B–Gly/Ser linker–HexaHisTag–PduA*, referred to as 109 
CC-Di-A–PduA* and CC-Di-B–PduA*. A control plasmid harboring the fusion without the CC-110 
Di-A/B module, i.e. containing only the Gly/Ser linker–HexaHisTag (C–PduA*), was also 111 
made. Plasmids were transformed individually into E. coli cells and the resulting strains were 112 
grown, induced and analyzed by transmission electron microscopy (TEM) after fixation, 113 
embedding, thin sectioning and staining. 114 
Strains expressing PduA* alone generated parallel filaments spanning the length of the cell 115 
(Fig. 1a), and appear to interfere with septation (Supplementary Fig. 2). Unexpectedly, the 116 
strains producing the control C–PduA* and the CC-Di-A–PduA* did not form any filamentous 117 
structures (Fig. 1b and Supplementary Fig. 3). C–PduA* expression led to deposits of 118 
material at the poles of the cell, suggesting that the Gly/Ser linker and/or the hexa-histidine 119 
tag alone affects solubility of the fusion protein. This was not seen with CC-Di-A–PduA*, but 120 
it is not clear why filaments do not form with this construct. In both cases, western blots 121 
revealed only low levels of CC-Di-A–PduA* and C–PduA* fusions in comparison to untagged 122 
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PduA*, suggesting potential cytotoxicity of these proteins (Supplementary Fig. 4). In 123 
contrast, large amounts of CC-Di-B–PduA* were detected in the cells transformed with its 124 
plasmid (Supplementary Fig. 4), and this led to numerous filaments throughout the 125 
cytoplasm (Fig. 1c and Supplementary Fig. 5). These filaments had a similar 23.6 ± 2.78 126 
nm (n = 100) diameter to untagged PduA* filaments30, but the former were considerably 127 
shorter (Fig. 1d,e). Consequently, CC-Di-B–PduA* filaments were not aligned within cells, 128 
and they did not appear to disrupt cells. It is not clear why the CC-Di-B–PduA* filaments are 129 
shortened, but possibly the highly charged CC-Di-B peptide limits filament growth in some 130 
way.  131 
Characterization of the cytoscaffold. To probe the spatial localization and organization of 132 
the shorter CC-Di-B–PduA* filaments, thicker thin sections (250 nm) were cut and prepared 133 
for TEM tomography. Analysis of the resulting tomogram confirmed the presence of the 134 
shorter filaments throughout the cytoplasm, except in a central region that is largely 135 
occupied by genomic DNA (Fig. 1f). Using methods developed to track microtubule 136 
assemblies in cells34, these structures were rendered and visualized in three dimensions 137 
(Fig. 1f and Supplementary Videos 1 and 2). This made clear that the filaments were not 138 
aligned but arrayed with multiple orientations, resulting in the appearance of an internal 139 
matrix. Analysis of these filaments revealed an average length of 161.2 ± 102.4 nm (n = 140 
739); although, due to the limitation of a 250 nm thin section, the true length is likely longer 141 
than this (Fig. 1e). 142 
To test the robustness of the CC-Di-B–PduA* filaments, and to interrogate their structure in 143 
more detail, the filaments were purified from cells using protocols developed for BMC 144 
isolation21. Cells were lysed and the filaments were purified by combining centrifugation and 145 
differential salt precipitation (Supplementary Fig. 6). Purified filaments were analyzed by 146 
TEM and AFM. Both confirmed intact filaments, and these approaches provided the 147 
opportunity to gain greater insight into the molecular organization of these structures 148 
(Supplementary Fig. 7). These ex vivo filaments tended to cluster together on the TEM 149 
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grids and AFM substrates. This clustering was also seen, though to a lesser extent, in some 150 
thin sections of whole cells visualized by TEM.  151 
Targeting to and functionalization of the cytoscaffold. Next, we tested if the CC-Di-B 152 
peptides of the CC-Di-B–PduA* filaments were available for targeting by other proteins 153 
labelled with CC-Di-A using the fluorescent protein citrine. To do this, we made CC-Di-A–154 
citrine and C–Citrine constructs similar in design to the fusion proteins described above. By 155 
cloning these constructs in compatible plasmids, they could either be transformed alone or 156 
co-transformed with the plasmid producing CC-Di-B–PduA*. 157 
On their own, both CC-Di-A–Citrine and C–Citrine produced uniform fluorescence 158 
throughout the cells, consistent with soluble, cytoplasmic proteins (Supplementary Fig. 8).  159 
Similarly, when co-expressed with CC-Di-B–PduA*, the C–Citrine control produced 160 
fluorescence distributed throughout the cell. In contrast, co-expression of CC-Di-A–Citrine 161 
and CC-Di-B–PduA* produced more punctate fluorescence, and reduced fluorescence 162 
around the genomic DNA (Fig. 2a). This is consistent with CC-Di-A–Citrine being localized 163 
to the filamentous scaffold. Correlative Light Electron Microscopy (CLEM)35,36 of high-164 
pressure frozen cells co-expressing CC-Di-A–GFP and CC-Di-B–PduA* confirmed the 165 
localization of fluorescence to the intracellular filamentous network (Fig. 2b–e). Control 166 
strains expressing the CC-Di-B–PduA* filaments with untagged GFP showed only a 167 
cytoplasmic signal (Supplementary Fig. 9). Expression of CC-Di-B–Citrine with or without 168 
CC-Di-B–PduA* resulted in punctate fluorescence, suggesting self-association of the CC-Di-169 
B peptide (Supplementary Fig. 8). 170 
To demonstrate that multiple cargo proteins could be directed to the cytoscaffold, CC-Di-A–171 
Citrine and a CC-Di-A–mCherry fusion were co-produced in cells with CC-Di-B–PduA* 172 
filaments. This gave similar patterns to those observed with CC-Di-A–Citrine plus CC-Di-B–173 
PduA*, and the mCherry and citrine signals co-localized (Fig. 2f–h). 174 
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While the results clearly demonstrate that fluorescent protein can be localized to the PduA* 175 
filaments through the use of the coiled-coil interaction, we also wanted to investigate if 176 
enzymes could be pegged onto the PduA* filaments in a similar fashion.  To investigate this, 177 
pyruvate decarboxylase (Pdc) and alcohol dehydrogenase (Adh) were both tagged with the 178 
CC-Di-A peptide and co-expressed with and without the CC-Di-B–PduA* filaments. 179 
Intriguingly, strains expressing Pdc and Adh grew to a substantially higher OD600 in 180 
comparison to both control strains (Supplementary Fig. 10a). GC/MS analysis of the growth 181 
medium revealed that the introduction of the CC-Di-B–PduA* filamentous network increased 182 
ethanol production by 221% per OD unit (t = 120 hrs) in comparison to a strain expressing 183 
Pdc and Adh but not the cytoscaffold (Fig. 3 and Supplementary Fig. 10b). Western blot 184 
analysis showed that this increase in ethanol production was not due to increased protein 185 
expression: indeed, the levels of Pdc and Adh were actually reduced by 48 ± 13.3 % and 26 186 
± 5.5 %, respectively, in the strain expressing CC-Di-A-tagged enzymes in the presence of 187 
the CC-Di-B–PduA* filaments (Supplementary Fig. 11). The presence of filaments in these 188 
strains was confirmed by TEM analysis (Supplementary Fig. 12). These experiments 189 
provide strong evidence that the localization of enzymes onto the PduA* scaffold 190 
substantially enhances an engineered metabolic pathway. 191 
As a final demonstration of the modularity, versatility and potential utility of the new 192 
cytoscaffold, we tested if it could be directed to the cytoplasmic side of the inner membrane 193 
of E. coli (Fig. 4). For this, we added the C-terminal membrane-localizing region of MinD 194 
from B. subtilis to the CC-Di-A–Citrine fusion to render CC-Di-A–Citrine–MinD37. When 195 
expressed in cells and imaged by confocal fluorescence microscopy, halos around the 196 
cytoplasm were evident, indicating localization of the citrine to the cell membrane (Fig. 4b). 197 
This was also the case for the C–Citrine–MinD control (Supplementary Fig. 13). When 198 
each of these were co-expressed with CC-Di-B–PduA* filaments, we observed differences in 199 
location between control and membrane-targeting constructs (Fig. 4a).  200 
Lee et al. Engineered bacterial cytoscaffolds  9
First, in cells expressing CC-Di-B–PduA* alone, an average 30% of the filaments were 201 
associated with the membrane. For CC-Di-B–PduA* plus the C–Citrine–MinD control this 202 
localization was very similar (31%). In contrast, for the CC-Di-B–PduA* plus CC-Di-A–203 
Citrine–MinD combination, 60% of the filaments were localized to the inner membrane, and 204 
this difference was statistically significant (p < 0.01). One-way ANOVA showed no significant 205 
difference (p < 0.01) in the total number of filaments between the three strains. Collectively, 206 
these analyses demonstrated that the cellular spatial location of the CC-Di-B–PduA* 207 
filaments can be controlled by interactions with the cognate de novo-designed coiled-coil 208 
pair. 209 
 210 
Discussion: 211 
Previously, we and others have shown that individual shell proteins, which form the 212 
hexameric tiles of the BMC casing, generate long filamentous macromolecular structures 213 
when overproduced in the host bacterial cells30,38. These structures are particularly apparent 214 
with PduA* from the propanediol utlization BMC. The filaments formed by PduA* are approx. 215 
20 nm in diameter.  They can be several microns long and have a tendency to stack 216 
together and align along the length of the cell, to the extent that they interfere with cell 217 
septation. We hypothesized that the PduA* filaments could be formed from the self-218 
association of the hexameric tiles into a protein sheet that then rolls into a nanotubule 219 
filament. We wondered if it would be possible to target specific proteins to these filaments to 220 
generate higher-order supramolecular organization the cell by design. 221 
To achieve this we have employed a heterodimeric coiled-coil system, CC-Di-A and CC-Di-B 222 
(ref. 31), previously characterized and used, for example, in the de novo construction of 223 
peptide cages33. We found that whilst fusion of the CC-Di-A sequence onto PduA* resulted 224 
in low protein production and loss of filament formation, the attachment of CC-Di-B to PduA* 225 
led to the formation of much shorter filaments that were dispersed throughout the cytoplasm. 226 
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The reason for the shorter filaments is not clear, but could be due to a slight frustration of 227 
hexamer packing when the positively charged CC-Di-B is appended, or from faster 228 
nucleation of CC-Di-B–PduA* fusions resulting in a greater number of shorter filaments. 229 
Importantly, given the quantity of filaments that are produced throughout the cell, their 230 
formation and presence did not appear to alter cell viability or growth. 231 
By adding the complementary CC-Di-A peptide onto fluorescent proteins we showed through 232 
imaging techniques that these tagged proteins can be recruited to the CC-Di-B–PduA* 233 
filaments, demonstrating that the filaments can act as molecular scaffold. A key 234 
biotechnological use of scaffolds within a cell would be to localize biosynthetic enzymes in 235 
close proximity to one another in order to facilitate metabolic channeling. This is part of the 236 
theory behind multi-enzyme complexes, although in these cases, direct transfer or 237 
channeling of metabolites from one enzyme to the next also takes place. Using simple 238 
systems it has been shown that compartmentalization of pyruvate decarboxylase and 239 
alcohol dehydrogenase within a recombinant BMC improves production of ethanol from 240 
pyruvate21. Similarly, the direct fusion of these two enzymes also results in improved flux39, 241 
indicating, in both cases, that having the second enzyme in close proximity to the first 242 
ensures that the unstable acetaldehyde intermediate is more efficiently converted into the 243 
alcohol. Therefore, we targeted pyruvate decarboxylase and alcohol dehydrogenase to the 244 
PduA filaments using the coiled-coil modules, and much more ethanol was produced in 245 
comparison to when the enzymes were expressed in the absence of the scaffold. This 246 
provides very strong evidence that the PduA scaffolds can be used to cluster metabolic 247 
enzymes in order to accelerate the channeling of intermediates from one enzyme to the 248 
next. 249 
The CC-Di-B peptide can also be used to control the localization of the PduA filaments 250 
within the cell. This was achieved by targeting the CC-Di-A-Citrine protein to the inner 251 
membrane by fusing on the MinD membrane-targeting region to the C terminus of the 252 
construct. Co-expression of this CC-Di-A–Citrine–MinD protein with CC-Di-B–PduA* directed 253 
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filaments to the inner-membrane surface. Such localization strategies could be used to 254 
ensure that pathway-enriched filaments have ready access to metabolites that are taken up 255 
via transporters, or conversely to ensure that products are generated near the membrane for 256 
export out of the cell.  257 
Furthermore, the fact that the CC-Di-B–PduA* filaments are able to interact easily with either 258 
cytosolic proteins or membrane-targeted proteins containing the CC-Di-A peptide suggests 259 
that the N-terminal region of PduA must be solvent-exposed. The two sides of the hexameric 260 
PduA tiles are distinguished by their concave and convex appearance, respectively. The N 261 
terminus of PduA, to which CC-Di-B is fused, is located on the concave side of the protein. 262 
The fact that this CC-Di-B peptide is available for interaction with a CC-Di-A-tagged protein 263 
strongly implies that the filament formed from PduA is generated with the concave side 264 
exposed to the solvent. This agrees with the recent structure of a recombinant BMC, where 265 
all the shell proteins were found to be oriented with the concave side facing out of the 266 
structure23. 267 
Overall, this work demonstrates a concept for performing and evaluating rational protein 268 
design in the cell, specifically, making hybrid scaffolds comprising de novo-designed 269 
peptides and natural proteins, which can be engineered on the micron scale within the E. 270 
coli cytoplasm. Visualization of filaments with and without appended ancillary proteins, and 271 
of those broadly distributed filaments or those localized to the inner membrane, 272 
demonstrates the potential of the system as a universal scaffold for the attachment, 273 
dispersion or localization of targeted cargo throughout the cell. We believe that these 274 
features and properties of the cytoscaffold, coupled with its ease of decoration and 275 
remodelling within cells, will enable applications in biotechnology and synthetic biology. 276 
More generally, this ability to design and engineer proteins in the cell could usher in a new 277 
era of rational protein design and engineering in vivo.   278 
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 409 
 410 
Figure Legends 411 
 412 
Figure 1. Transmission electron micrographs and analysis of PduA*-based constructs 413 
and filaments in E. coli. (a) Untagged PduA* filaments. (b,c) CC-Di-A–PduA* (b) and CC-414 
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Di-B–PduA* (c) filaments.  Scale bars in a–c, 200 nm. (d) Histogram showing the diameter 415 
of CC-Di-B-PduA* filaments (n = 100). (e) Histogram showing lengths of CC-Di-B-PduA* 416 
filaments based on a 250 nm tomogram rendering shown in f (n = 739). (f) 3D render of CC-417 
Di-B–PduA* filaments in E. coli based on a 250 nm tomogram. Scale bar in f, 500 nm. See 418 
also Supplementary Video 1. 419 
 420 
Figure 2. Localization of fluorescent proteins to a bacterial cytoscaffold. (a) Co-421 
expression of CC-Di-B–PduA* with CC-Di-A–Citrine, indicated by Citrine fluorescence.  (b–422 
e) Correlative Light Microscopy of a strain expressing CC-Di-B–PduA* and CC-Di-A–GFP, 423 
encompassing TEM (b), GFP fluorescence (c), overlay (d), and detail of the overlaid image 424 
(e). (f–h) Fluorescence of cells expressing CC-Di-B–PduA*, CC-Di-A–Citrine, and CC-Di-A–425 
mCherry, including Citrine signal (f), mCherry signal (g), and overlay of the two (h). Scale 426 
bars in a,f–h, 5 µm; scale bars in b–e, 500 nm. 427 
 428 
Figure 3. Ethanol production in vivo. Graph showing ethanol content of the growth 429 
medium over time normalized to an OD600 = 1. Open circles, E. coli strain transformed with 430 
empty plasmids (pET14b and pLysS); closed circles, strain producing CC-Di-B–PduA* only; 431 
open triangles, strain producing CC-Di-A–Pdc and CC-Di-A–Adh; closed triangles, strain 432 
producing CC-Di-A–Pdc, CC-Di-A–Adh and CC-Di-B–PduA*. Data points represent an 433 
average of three independent experiments; error bars, s.d. 434 
 435 
Figure 4. Targeting the bacterial cytoscaffold to the inner membrane of E. coli. (a) Box-436 
and-whisker plots showing the number of filaments associated with the inner membrane for 437 
3 strains expressing variants of the CC-Di-A/B–PduA* system. Plot 1 = CC-Di-B-PduA*, Plot 438 
2 = CC-Di-B–PduA* + CC-Di-A–Citrine–MinD, Plot 3 = CC-Di-B–PduA* + CC-Di-C–Citrine–439 
MinD. Boxes show first and third quartiles, solid line shows median, dotted lines give the 440 
mean and whiskers the minimum and maximum; 250 cells were analyzed for each of the 3 441 
strains. Statistically significant differences (p=0.01) are indicated by **.  (b) Confocal image 442 
of strain expressing CC-Di-A–Citrine–MinD. Scale bar, 5 µm. (c) TEM micrograph of strains 443 
producing CC-Di-B–PduA* plus CC-Di-A–Citrine–MinD. Arrows indicate transverse 444 
filaments. (d) Zoom in of area 1 in c. Scale bars in c and d, 200 nm. 445 
  446 
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Online Methods: 447 
Cloning of coiled-coil fused constructs. DNA encoding CC-Di-A and CC-Di-B embedded 448 
within a GS linker followed by a hexahistidine tag and a thrombin cleavage sequence was 449 
synthesized and cloned into the XbaI/ NdeI sites of pET14b. A control sequence containing 450 
only a GS linker, hexahistidine tag and thrombin cleavage sequence was also synthesized 451 
and cloned by the same strategy. Synthesized DNA sequences and amino acid sequences 452 
are shown in Supplementary Table 2. 453 
Expression of coiled coil constructs. E. coli BL21 * (DE3) competent cells were 454 
transformed with a plasmid (s) containing the gene(s) of interest, and plated onto LB agar 455 
plates supplemented with appropriate antibiotics (ampicillin 100 mg/L and/ or 456 
chloramphenicol 34 mg/L).  For TEM analysis 50 mL of LB was inoculated 1:100 from an 457 
overnight starter culture and grown at 37 °C with shaking to an OD600 of ~ 0.4, protein 458 
production was induced by the addition of IPTG to a final concentration of 400 µM, cultures 459 
were subsequently incubated overnight at 19 °C with shaking. For time course analysis 500 460 
mL of LB was inoculated, grown and induced as described previously. At time intervals 50 461 
mL of media was removed for TEM analysis. For purification of nanotubes 250 mL LB was 462 
inoculated 1:100 from an overnight starter culture and grown 37 °C to an OD600 ~ 0.4. 463 
Protein production was induced by addition of IPTG to a final concentration of 400 µM, 464 
cultures were then incubated with shaking at 19 °C overnight. For confocal imaging 465 
experiments 50 mL of LB was inoculated 1:100 from an overnight starter culture and grown 466 
with shaking at 37 °C to an OD600 ~ 0.4. protein production was induced by addition of IPTG 467 
to a final concentration of 400 µM, cultures were then incubated with shaking at 19 °C for 4 468 
hours. 469 
In vivo ethanol production. For in-vivo ethanol production, 100 mL of LB supplemented 470 
with 4% glucose and appropriate antibiotics was inoculated from overnight starter cultures to 471 
a starting OD600 of 0.05; cultures were grown at 28 °C for 120 hours with shaking at 150 rpm. 472 
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Protein production was induced by addition of IPTG to a final concentration of 400 µM after 4 473 
hours of growth. During growth, 1 mL samples were removed at 0, 2, 4, 6, 12, 24, 48, 72, 96 474 
and 120 hours for GC/MS analysis of the growth medium. Samples (1 mL) were also taken 475 
at each time point for SDS-PAGE analysis. Additional samples (5 mL) were taken after 24 476 
hours for TEM analysis. 477 
Western blot analysis. Nitrocellulose membranes following transfer and blocking were 478 
incubated in primary antibody (rabbit anti-PduA 1 μg/ mL or mouse anti-His (Sigma Aldrich) 479 
1:3000) followed by incubation in a secondary antibody coupled to alkaline phosphatase 480 
(Goat Anti-Rabbit IgG (H+L) Alkaline Phosphatase Conjugate (Bio-Rad) 1:3000 or Anti-481 
Mouse IgG (H+L), AP Conjugate (Promega) 1:5000). Bands were visualized by incubation in 482 
substrate 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT). 483 
TEM analysis of cells. Cells grown as described previously were harvested by 484 
centrifugation at 3000 x g for 10 minutes. The cell pellet was resuspended in 2 mL 2.5% 485 
(w/v) glutaraldehyde in 100 mM sodium cacodylate buffer pH 7.2 (CAB) and fixed for 2 hours 486 
with gentle rotating (20 rpm). Cells were pelleted by centrifugation at 6000 x g for 2 minutes 487 
and were washed twice for 10 minutes with 100 mM CAB. Cells were post-fixed with 1% 488 
(w/v) osmium tetroxide in 100 mM CAB for 2 hours and subsequently washed twice with 489 
ddH2O. Cells were dehydrated by incubation in an ethanol gradient, 50% EtOH for 10 490 
minutes, 70% EtOH overnight, 90% EtOH for 10 minutes followed by three 10 minute 491 
washes in 100% dry EtOH. Cells were then washed twice with propylene oxide for 15 492 
minutes. Cell pellets were embedded by resuspension in 1 mL of a 1:1 mix of propylene 493 
oxide and Agar LV Resin and incubated for 30 minutes with rotation. Cell pellets were 494 
infiltrated twice in 100% Agar LV resin. The cell pellet was re-suspended in fresh resin and 495 
transferred to a 1 mL Beem embedding capsule, centrifuged for 5 minutes at 3000 x g to 496 
concentrate the cells to the tip of the mould and incubated for 20 hours at 60 °C to 497 
polymerize.  498 
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Samples were ultra-thin sectioned on a RMC MT-XL ultra-microtome with a diamond knife 499 
(diatome 45°). Sections (60 – 70 nm) were collected on un-coated 300 mesh copper grids. 500 
Grids were stained by incubation in 4.5% (w/v) uranyl acetate in 1% (v/v) acetic acid solution 501 
for 45 minutes followed by washing in a stream of ddH2O. Grids were then stained with 502 
Reynolds lead citrate for 7 minutes followed by washing in a stream of ddH2O. Electron 503 
microscopy was performed using a JEOL-1230 transmission electron microscope equipped 504 
with a Gatan multiscan digital camera operated at an accelerating voltage of 80 kV 505 
Tomography. Sections (250 nm) were cut from the existing blocks and 15nm gold fiducials 506 
(Aurion, TomoSol solution) were applied to both surfaces of the sections. The sections were 507 
imaged at 200 kV in a Tecnai 20 TEM (FEI, the Netherlands) and double tilt series images 508 
acquired between -62° to +69.5° (first axis) and -68° to +69.5° (second axis) with 1.5° 509 
(above 50°) and 2° increments (below 50°). The pixel size on the 4k by 4k FEI Eagle camera 510 
was 0.74nm. The resulting tomograms were reconstructed and combined using IMOD 511 
software40,41. The tube-like structures were modelled automatically using the AMIRA 512 
XTracing Extension of the AMIRA software suite, developed for automatic tracing of 513 
microtubules34. A cylinder template is correlated with the data to find and search for the 514 
centre lines of tubes.  A small cropped area was used to refine the fitting parameters as 515 
shown in Supplementary Movie S2 and these were then applied to the full data set. AMIRA 516 
software was further used for visualizing the data. 517 
Measurements of in vivo nanotubes. Diameter measurements of 100 nanotubes from 10 518 
cells were calculated in ImageJ42. Length measurements were calculated automatically 519 
using the XTracing extension of the AMIRA software suite. Cropping box measurements 520 
were removed manually from the dataset, leaving a total of 739 tubes. 521 
Purification of CC-Di-B-PduA*. CC-Di-B tagged PduA* was overproduced as described 522 
previously. Cells were harvested by centrifugation at 2683 x g. A 1 g wet cell pellet was 523 
resuspended in 20 mL Yeast Protein Extraction Reagent (Thermo Scientific) supplemented 524 
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with Protease Inhibitor Cocktail Tablets, EDTA-Free (Sigma-Aldrich) and 500 Units 525 
Benzonase® Nuclease (Merck) and incubated for 3 hours at room temperature with gentle 526 
shaking. CC-Di-B-PduA* nanotubes were pelleted from the lysate by centrifugation for 5 527 
minutes at 11,300 x g, the pellet was resuspended in 2 mL of 20 mM Tris-HCl, pH 8, 528 
containing 20 mM NaCl. The suspension was centrifuged for 5 minutes at 11,000 x g, the 529 
resulting nanotube containing pellet was resuspended in 20 mM Tris-HCl, pH 8, and 530 
centrifuged again as above. The supernatant was removed and adjusted with a solution of 531 
5M NaCl to give a final concentration of 80 mM. A final centrifugation step as above was 532 
performed and the resulting pellet was analyzed for the presence of PduA* nanotubes. 533 
Analysis of purified nanotubes. TEM: Following purification, 20 µL of CC-Di-B-PduA* 534 
nanotubes were deposited onto formvar, carbon coated 300 mesh copper grids and 535 
incubated to 5 minutes. Glutaraldehyde (20 µL of 2.5 % (v/v)) in PBS was then added and 536 
incubated for a further 5 minutes before washing in 3 drops of 2.5 % (v/v) glutaraldehyde in 537 
PBS followed by 3 drops of ddH2O. Grids were stained with 2% (w/v) aqueous uranyl 538 
acetate and subsequently dried. Electron microscopy was performed using a JEOL-1230 539 
transmission electron microscope equipped with a Gatan multiscan digital camera operated 540 
at an accelerating voltage of 80 kV. 541 
AFM: Purified CC-Di-B-PduA* nanotubes (20 µL) nanotubes were deposited onto freshly 542 
cleaved mica surfaces and incubated for 5 minutes followed by the addition of 20 µL 2.5 % 543 
(v/v) glutaraldehyde in PBS. Surfaces were washed 3 times with 1 mL of ddH2O then dried 544 
under a gentle stream of N2. Images were acquired in air at 20 °C using a Bruker MultiMode 545 
8 Scaning probe microscope operating under Peak-Force tapping mode (ScanAsyst, Bruker) 546 
with a ScanSsyst-air probe (Bruker). Areas (10 µm x 10 µm) were scanned at a resolution of 547 
4096 x 4096 pixels. Bow and tilt were removed using NanoScope Analysis 1.4 (Bruker). 548 
Confocal imaging. Following growth and induction of protein expression 1 mL of cells was 549 
harvested by centrifugation at 3000 x g. The resulting cell pellet was washed 3 times in PBS 550 
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before incubation for 15 minutes in 2% (w/v) formaldehyde in PBS, cells were then washed a 551 
further 3 times in PBS. Cells (10 µL) were pipetted onto a 1.5 thickness coverslip before 552 
being inverted onto a drop of ProLong Gold antifade mountant (Life Technologies) on a 553 
glass slide Slides were incubated at room temperature in the dark for 24 hours to cure. 554 
Images were acquired on a Leica TCS SP8 system attached to a Leica DMi8 inverted 555 
microscope (Leica Microsystems). Excitation light (514 nm for mCitrine or 594 nm for 556 
mCherry) was provided by a white light laser with a repetition rate of 80 MHz. Images were 557 
acquired using a 100 x 1.4 NA oil immersion objective and fluorescence was detected 558 
through bandpasses of 520 – 570 nm (mCitrine detection) or 600 - 650 nm (mCherry 559 
detection).  560 
Correlative Light Electron Microscopy. Cells were harvested by centrifugation at 3000 x g 561 
for 5 minutes. Cells (1μL) were loaded into a 0.1 mm membrane carrier (Leica) and vitrified 562 
by high pressure freezing (EMPACT2 + RTS, Leica). Frozen membrane carriers were 563 
transferred into 1 mL of freeze substitution medium (0.2% uranyl acetate, 5% H2O, in 564 
acetone) and held at -90°C for 5 hours in an automated freeze substitution unit (AFS2, 565 
Leica) equipped with an attachment for automated reagent exchange (Freeze Substitution 566 
Processor, FSP, Leica) (30). Samples were warmed to -45°C at a rate of 5 °C/hour, held at -567 
45°C for 2 hours before washes in acetone and ethanol for 30 minutes each. Samples were 568 
then infiltrated with 25, 50 and 75% dilutions of Lowicryl HM20 resin for 3 hours each before 569 
infiltrating with 100% resin overnight, followed by a further 3 changes of resin for 2 hours 570 
each. UV polymerization was performed over approximately 48 hours; initially at -45°C for 16 571 
hours, before warming to 0°C at a slope of 5°C/hour and finally at 0°C for approximately 14 572 
hours.  573 
Following polymerization, blocks were removed from flow through containers and carriers 574 
were detached using liquid nitrogen and the specimen carrier detaching tool (Leica) heated 575 
to 40°C. Blocks were trimmed and sectioned with a 45° diamond knife using an EM UC6 576 
microtome (Leica). 70 and 300 nm thick sections were collected on carbon-coated pioloform 577 
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films on H6 copper finder grids (Agar Scientific). Grids were air dried, mounted in PBS 578 
between a glass slide and coverslip and imaged by light microscopy using a Leica DMI4000 579 
B inverted epifluorescence microscope fitted with a 63x oil immersion lens (NA 1.4). After 580 
imaging, the grids were washed in H2O and air dried before imaging in TEM. Image 581 
registration of light and electron microscopy images was performed using the eC-CLEM 582 
plugin in ICY43.  583 
Analysis of enzyme levels. Relative amounts of Pdc and Adh were quantified by western 584 
blot. Total cell lysate samples, adjusted to cell number were analyzed by SDS-PAGE and 585 
subsequently western blot analysis. Peak areas were quantified using the gel analysis tool in 586 
Image J. Due to the higher molecular weight band close to CC-Di-A-Adh half of this peak 587 
was quantified on the assumption that the peak was symmetrical. Measurements were 588 
repeated for each of the cultures. 589 
MinD colocalization . DNA encoding the c-terminal membrane-associating region of MinD 590 
was synthesized and cloned into the SpeI/BlpI sites of pET_CC_Di_A_Citrine_No_Stop and 591 
pET_C_Citrine_No_Stop. Cells were transformed as described previously and grown in LB 592 
media at 37 °C with shaking to an OD600 ~ 0.4, protein production was induced by addition of 593 
IPTG to a final concentration of 400 µM. Cultures were then incubated with shaking at 19 °C 594 
for 4 hours. Cells were harvested, fixed, embedded and sectioned as described previously. 595 
A total of 250 cells in the transverse orientation for each strain were analyzed for the 596 
presence and location of transverse CC-Di-B-PduA* nanotubes. Statistical analysis was 597 
performed in Minitab Software version 17 using a one-way ANOVA (Analysis of Variance) at 598 
the 99% level with posthoc analysis by Tukey’s test. 599 
 600 
 601 
 602 
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Data Availability Statement 603 
All data generated or analyzed during this study are included in this published article (and 604 
supplementary information files) or are available from the corresponding authors on 605 
reasonable request. 606 
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